Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q2 FY24 results · Jul–Sep 2023

Advanced Enzyme Technologies reported revenue from operations of ₹157.84 crore (up 13.8% from Q2 FY23) and net profit of ₹35.20 crore (up 34.0% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations157.84138.69+13.8%147.28+7.2%
Other income6.093.87+57.5%6.67−8.7%
Total income163.94142.56+15.0%153.95+6.5%
Profit before tax47.9334.14+40.4%41.41+15.7%
Net profit for the period35.2026.26+34.0%29.38+19.8%
Attributable to shareholders of the company34.4126.21+31.3%28.81+19.4%
EPS, basic (₹)3.082.34+31.6%2.58+19.4%
Net margin (%)22.318.919.9
Standalone · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations96.5877.18+25.1%85.35+13.2%
Other income0.792.00−60.7%51.25−98.5%
Total income97.3679.18+23.0%136.60−28.7%
Profit before tax24.7618.41+34.5%73.48−66.3%
Net profit for the period18.3813.62+35.0%67.49−72.8%
EPS, basic (₹)1.641.22+34.4%6.04−72.8%
Net margin (%)19.017.679.1
Consolidated
Filed with BSE
20 Nov 2023, 15:05 IST
Board meeting
07 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
20 Nov 2023, 15:05 IST
Board meeting
07 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE